A series of 2,4(1H,3H)-quinazolinedione derivatives: synthesis and biological evaluation as potential anticancer agents
buir.contributor.author | Çetin-Atalay, Rengül | |
buir.contributor.author | Gözen, Damla | |
dc.citation.epage | 76 | en_US |
dc.citation.issueNumber | 1 | en_US |
dc.citation.spage | 64 | en_US |
dc.citation.volumeNumber | 13 | en_US |
dc.contributor.author | Akgün, H. | en_US |
dc.contributor.author | Us-Yılmaz, D. | en_US |
dc.contributor.author | Çetin-Atalay, Rengül | en_US |
dc.contributor.author | Gözen, Damla | en_US |
dc.date.accessioned | 2018-04-12T10:59:09Z | |
dc.date.available | 2018-04-12T10:59:09Z | |
dc.date.issued | 2016 | en_US |
dc.department | Department of Molecular Biology and Genetics | en_US |
dc.department | Genetics and Biotechnology Research Center (BİLGEN) | en_US |
dc.description.abstract | A series of 6,7-disubstituted-3-{2-[4-(substituted)piperazin-1-yl]-2-oxoethyl}quinazoline- 2,4(1H,3H)-dione derivatives (7-34) were synthesized and their structures were elucidated on the basis of analytical and spectral (UV, IR, 1H-NMR, 13C-NMR and MS) data. These synthesized compounds were evaluated for their in vitro cytotoxicities against a panel of three human cancer cell lines. According to the cytotoxicity screening results, 3-{2-[4-(4-chlorobenzyl)piperazin-1-yl]-2-oxoethyl} quinazoline-2,4(1H,3H)-dione (7) presented the highest activity against HUH-7, MCF-7 and HCT-116 cell line with the IC50 values of 2.5, 6.8 and 4.9 µM, respectively. | en_US |
dc.description.provenance | Made available in DSpace on 2018-04-12T10:59:09Z (GMT). No. of bitstreams: 1 bilkent-research-paper.pdf: 179475 bytes, checksum: ea0bedeb05ac9ccfb983c327e155f0c2 (MD5) Previous issue date: 2016 | en |
dc.identifier.doi | 10.2174/1570180812666150529204909 | |
dc.identifier.issn | 1570-1808 | |
dc.identifier.uri | http://hdl.handle.net/11693/36985 | |
dc.language.iso | English | en_US |
dc.publisher | Bentham Science Publishers | en_US |
dc.relation.isversionof | https://doi.org/10.2174/1570180812666150529204909 | |
dc.source.title | Letters in Drug Design and Discovery | en_US |
dc.subject | Anticancer | en_US |
dc.subject | Cytotoxicity | en_US |
dc.subject | Piperazine | en_US |
dc.subject | Quinazoline | en_US |
dc.subject | Quinazoline-2,4(1H,3H)-dione | en_US |
dc.subject | Sulforhodamine B method | en_US |
dc.title | A series of 2,4(1H,3H)-quinazolinedione derivatives: synthesis and biological evaluation as potential anticancer agents | en_US |
dc.type | Article | en_US |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- A Series of 2,4(1H,3H)-Quinazolinedione derivatives Synthesis and biological evaluation as potential anticancer agents.pdf
- Size:
- 305.77 KB
- Format:
- Adobe Portable Document Format
- Description:
- Full printable version